serw-MX  [xml]  
 


    
 Categorias DeCS

G07 Physiological Phenomena .
G07.690 Pharmacological and Toxicological Phenomena .
G07.690.773 Pharmacological Phenomena .
G07.690.773.968 Drug Interactions .
G07.690.773.968.755 Herb-Drug Interactions .
K01 Humanities .
K01.752 Philosophy .
K01.752.566 Morals .
K01.752.566.479 Ethics .
K01.752.566.479.830 Principle-Based Ethics .
K01.752.566.479.830.500 Beneficence .
N03 Health Care Economics and Organizations .
N03.219 Economics .
N03.219.151 Costs and Cost Analysis .
N03.219.151.125 Cost-Benefit Analysis .
N03.219.521 Financing, Organized .
N03.219.521.576 Insurance .
N03.219.521.576.130 Insurance Benefits .
N03.219.521.576.343 Insurance, Health .
N03.219.521.576.343.575 Insurance, Pharmaceutical Services .
N05 Health Care Quality, Access, and Evaluation .
N05.350 Ethics .
N05.350.958 Principle-Based Ethics .
N05.350.958.500 Beneficence .
SP4 Environmental Health .
SP4.006 Environmental Engineering .
SP4.006.067 Environmental Economics .
SP4.006.067.548 Cost-Benefit Analysis .
SP4.051 General Aspects .
SP4.051.497 Costs and Cost Analysis .
SP4.051.497.018 Cost-Benefit Analysis .
SP8 Disasters .
SP8.473 Risk 17142 .
SP8.473.981 Disaster Vulnerability .
SP8.473.981.937 Socioeconomic Factors .
SP8.473.981.937.872 Cost-Benefit Analysis .
SP8.946 Disaster Management .
SP8.946.351 Impact of Disasters .
SP8.946.351.424 Damage Assessment Methodologies .
SP8.946.351.424.432 Cost-Benefit Analysis .
SP8.946.819 Prevention and Mitigation .
SP8.946.819.784 Cost-Benefit Analysis .
 
 Termos
 Sinônimos e Históricos
Documentos
LILACS e MDL
 
Insurance, Pharmaceutical Services .
Insurance, Pharmaceutic Services .
Insurance, Pharmacy Services .
Pharmaceutic Services Insurance .
Pharmaceutical Services Insurance .
Pharmacy Services Insurance .
Drug Benefit Plan .
Insurance, Drug .
Insurance, Prescription .
Plan, Drug Benefit .
Plans, Drug Benefit .
Drug Benefit Plans .
Drug Insurance .
Prescription Insurance .
1.00
 
Cost-Benefit Analysis .
Benefits and Costs .
Cost Benefit .
Cost Benefit Analysis .
Cost-Effectiveness Analysis .
Cost-Utility Analysis .
Costs and Benefits .
Economic Evaluation .
Marginal Analysis .
Analyses, Cost Benefit .
Analyses, Cost-Benefit .
Analyses, Cost-Utility .
Analyses, Marginal .
Analysis, Cost Benefit .
Analysis, Cost-Benefit .
Analysis, Cost-Effectiveness .
Analysis, Cost-Utility .
Analysis, Marginal .
Cost Benefit Analyses .
Cost Benefit Data .
Cost Effectiveness Analysis .
Cost Utility Analysis .
Cost-Benefit Analyses .
Cost-Utility Analyses .
Data, Cost-Benefit .
Economic Evaluations .
Effectiveness, Cost .
Evaluation, Economic .
Evaluations, Economic .
Marginal Analyses .
Cost Effectiveness .
Cost-Benefit Data .
0.51
 
Herb-Drug Interactions .
Drug-Herb Interactions .
Drug-Plant Interactions .
Herbal Drug Interactions .
Plant-Drug Interactions .
Drug Herb Interactions .
Drug Interaction, Herbal .
Drug Interactions, Herbal .
Drug Plant Interactions .
Drug-Herb Interaction .
Drug-Plant Interaction .
Herb Drug Interactions .
Herb-Drug Interaction .
Herbal Drug Interaction .
Interaction, Drug-Herb .
Interaction, Drug-Plant .
Interaction, Herb-Drug .
Interaction, Herbal Drug .
Interaction, Plant-Drug .
Interactions, Drug-Herb .
Interactions, Drug-Plant .
Interactions, Herb-Drug .
Interactions, Herbal Drug .
Interactions, Plant-Drug .
Plant Drug Interactions .
Plant-Drug Interaction .
0.50
 
Insurance Benefits .
Insurance Beneficiary .
Beneficiaries, Insurance .
Beneficiary, Insurance .
Benefit, Health .
Benefit, Insurance .
Benefits, Health .
Benefits, Insurance .
Health Benefit .
Insurance Beneficiaries .
Insurance Benefit .
Health Benefits .
0.50
 
Beneficence .
Benevolence .
Nonmaleficence .
0.49